Literature DB >> 33161964

AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States.

Justin Greiwe1, John Oppenheimer2, J Andrew Bird3, David M Fleischer4, Jacqueline A Pongracic5, Matthew Greenhawt4.   

Abstract

The oral food challenge (OFC) is the criterion standard for diagnosing food allergy, but prior studies indicate many allergists may not be using OFCs for various reasons. To better understand current OFC trends, practices, and barriers, the American Academy of Allergy Asthma and Immunology (AAAAI) Adverse Reactions to Foods Committee subcommittee updated a 19-item survey (previously administered in 2009) and sent it to AAAAI and American College of Allergy, Asthma, and Immunology (ACAAI) membership. There were a total of 546 respondents who represented approximately a 10% response rate. Among the 546 respondents, compared with 2009, significantly more providers offer OFCs (95% vs 84.5%), offer >10 OFCs per month (17% vs 5.6%), obtain informed consent (82.2% vs 53.6%), and performed OFCs in fellowship (71% vs 45%) (all P < .001). Fellowship OFC training was limited, with 56% performing <10 OFCs in fellowship and 29% performing none. Although 94% see patients <12 months of age, 35.5% do not offer OFCs for early peanut introduction. Although 79% dedicate a supervising medical provider (MD, NP, PA) and 86% have a written OFC protocol, only 60% had a standardized reaction treatment protocol and 56% prepared emergency medications before OFC. Compared with 2009, there was significant worsening of perceived barriers to performing OFCs, including time (65.6% vs 55%), space (55.3% vs 27.1%), staffing (59.6% vs 44.3%), experience (16.9% vs 11.5%), and hospital proximity (10.9% vs 7.9%), though reimbursement as a barrier improved (45.9% vs 53.7%) (all P < .01). Compared with 2009, although more providers offer OFCs, multiple perceived barriers to performing OFCs have worsened. Hesitancy to challenge infants and emergency preparedness issues are emerging potential concerns.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Double-blinded food challenge; Epinephrine; IgE-mediated food allergy; Oral food challenge; Safety

Mesh:

Substances:

Year:  2020        PMID: 33161964     DOI: 10.1016/j.jaip.2020.07.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  6 in total

1.  Evaluation of a group visit model for access to infant and toddler oral food challenges.

Authors:  Ian R Roy; Arielle Hazi; Cynthia A Esteban; Mharlove André; Yamini Virkud; Wayne G Shreffler; Michael Pistiner
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-03

2.  Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice.

Authors:  Jay Portnoy; Christina E Ciaccio; Janet Beausoleil; George Du Toit; Stanley Fineman; Stephen A Tilles; June Zhang; Claire Lawrence; Mohamed Yassine; S Shahzad Mustafa
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-09       Impact factor: 3.373

3.  Qualitative interviews to understand health care providers' experiences of prescribing licensed peanut oral immunotherapy.

Authors:  Aikaterini Anagnostou; Claire Lawrence; Stephen A Tilles; Susan Laubach; Sarah M Donelson; Mohamed Yassine; Anna Nowak-Wegrzyn
Journal:  BMC Res Notes       Date:  2022-08-08

Review 4.  Transitioning peanut oral immunotherapy to clinical practice.

Authors:  S Lazizi; R Labrosse; F Graham
Journal:  Front Allergy       Date:  2022-08-26

5.  A pragmatic approach to infant feeding for food allergy prevention.

Authors:  Vicki McWilliam; Carina Venter; Matthew Greenhawt; Kirsten P Perrett; Mimi L K Tang; Jennifer J Koplin; Rachel L Peters
Journal:  Pediatr Allergy Immunol       Date:  2022-09       Impact factor: 5.464

6.  Mass food challenges in a vacant COVID-19 stepdown facility: Exceptional opportunity provides a model for the future.

Authors:  Aideen M Byrne; Juan Trujillo; John Fitzsimons; Tariq Mohammed; Robert Ghent; Cathryn O'Carroll; David Coghlan; Jonathan O'B Hourihane; Ali Alsalemi; Aoife Cassidy; Eva Corbet; Rita Creighton; Yvonne d'Art; Linda Farren; Rachel Flanagan; Niamh Flynn; Ruth Franklin; Claire Gray; Paul Harding; Ciara Hendrick; Fionnuala Heraghty; Sadhbh Hurley; Valerie Kavanagh; Dhanis Lad; Karen Leddy; Sarah Lewis; Triona McGlynn; Danielle O'Connor; Phil O'Neill; Orla O'Shea; Ann O'Toole; Rachel Quinn; Aisling Reid; Alison Russell; Emma Ruth; Anne Rynne; P Bhusan Sanneerappa; Mairead Sheehan; Claire Thompson; Ciara Tobin; James Trayer; Alison Wallace; Nicola Walsh; Fiona Wilson
Journal:  Pediatr Allergy Immunol       Date:  2021-07-28       Impact factor: 5.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.